DMC Biotech completed successful pilot of L-alanine at BPF in Delft

Matt Lipscomb, CEO of DMC

DMC Biotechnologies, the US BioBased specialty chemical company, has successfully produced its lead product, L-alanine at pilot scale. Commercial key performance metrics were achieved and performance from the bench scale was also demonstrated at 3m3scale fermentation and for each of the downstream purification unit operations.  The robustness of DMC’s Dynamic Metabolic Control technology to the process environment was also validated.

Continue reading